12-2668886-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_000719.7(CACNA1C):​c.4624-47A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00208 in 1,299,490 control chromosomes in the GnomAD database, including 51 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0098 ( 28 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 23 hom. )

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.12

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS2 (HGNC:40118): (CACNA1C antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-2668886-A-G is Benign according to our data. Variant chr12-2668886-A-G is described in ClinVar as [Benign]. Clinvar id is 695632.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0098 (1491/152214) while in subpopulation AFR AF = 0.0341 (1414/41524). AF 95% confidence interval is 0.0326. There are 28 homozygotes in GnomAd4. There are 698 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1491 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.4624-47A>G intron_variant Intron 37 of 46 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.4624-47A>G intron_variant Intron 37 of 46 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.4624-47A>G intron_variant Intron 37 of 46 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.4624-47A>G intron_variant Intron 37 of 46 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.4858-47A>G intron_variant Intron 39 of 49 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.4624-47A>G intron_variant Intron 37 of 47 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.4591-47A>G intron_variant Intron 36 of 46 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.4789-47A>G intron_variant Intron 38 of 47 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.4768-47A>G intron_variant Intron 39 of 48 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.4690-47A>G intron_variant Intron 37 of 46 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.4624-47A>G intron_variant Intron 37 of 47 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.4624-47A>G intron_variant Intron 37 of 47 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.4714-47A>G intron_variant Intron 37 of 46 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.4714-47A>G intron_variant Intron 37 of 46 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.4714-47A>G intron_variant Intron 37 of 46 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.4714-47A>G intron_variant Intron 37 of 46 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.4708-47A>G intron_variant Intron 38 of 47 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.4699-47A>G intron_variant Intron 38 of 47 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.4684-47A>G intron_variant Intron 38 of 47 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.4624-47A>G intron_variant Intron 37 of 46 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.4624-47A>G intron_variant Intron 37 of 46 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.4624-47A>G intron_variant Intron 37 of 46 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.4675-47A>G intron_variant Intron 37 of 46 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.4666-47A>G intron_variant Intron 37 of 46 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.4591-47A>G intron_variant Intron 36 of 45 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.4591-47A>G intron_variant Intron 36 of 45 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.4585-47A>G intron_variant Intron 36 of 45 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.4624-47A>G intron_variant Intron 37 of 46 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.4624-47A>G intron_variant Intron 37 of 46 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.4624-47A>G intron_variant Intron 37 of 46 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.4624-47A>G intron_variant Intron 37 of 46 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.4624-47A>G intron_variant Intron 37 of 46 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.4615-47A>G intron_variant Intron 37 of 46 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.4591-47A>G intron_variant Intron 36 of 45 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.00977
AC:
1486
AN:
152096
Hom.:
28
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0341
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00251
AC:
623
AN:
248632
AF XY:
0.00204
show subpopulations
Gnomad AFR exome
AF:
0.0345
Gnomad AMR exome
AF:
0.00165
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000133
Gnomad OTH exome
AF:
0.00199
GnomAD4 exome
AF:
0.00106
AC:
1218
AN:
1147276
Hom.:
23
Cov.:
16
AF XY:
0.000908
AC XY:
532
AN XY:
585822
show subpopulations
African (AFR)
AF:
0.0352
AC:
961
AN:
27276
American (AMR)
AF:
0.00183
AC:
81
AN:
44312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24208
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38156
South Asian (SAS)
AF:
0.0000876
AC:
7
AN:
79886
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53106
Middle Eastern (MID)
AF:
0.000584
AC:
3
AN:
5138
European-Non Finnish (NFE)
AF:
0.0000715
AC:
59
AN:
825066
Other (OTH)
AF:
0.00213
AC:
107
AN:
50128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
63
126
189
252
315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00980
AC:
1491
AN:
152214
Hom.:
28
Cov.:
32
AF XY:
0.00938
AC XY:
698
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0341
AC:
1414
AN:
41524
American (AMR)
AF:
0.00314
AC:
48
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68006
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
72
144
215
287
359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00326
Hom.:
3
Bravo
AF:
0.0116
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Long QT syndrome Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.77
DANN
Benign
0.52
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114898435; hg19: chr12-2778052; API